Authors: Jankun, J Skrzypczak-Jankun, E

Citation: J. Jankun et E. Skrzypczak-jankun, Binding site of amiloride to urokinase plasminogen activator depends on species, INT J MOL M, 8(4), 2001, pp. 365-371

Authors: Swiercz, R Keck, RW Skrzypczak-Jankun, E Selman, SH Jankun, J

Citation: R. Swiercz et al., Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostatecancer xenografts in SCID mice, ONCOL REP, 8(3), 2001, pp. 463-470

Authors: Skrzypczak-Jankun, E McCabe, NP Selman, SH Jankun, J

Citation: E. Skrzypczak-jankun et al., Curcumin inhibits lipoxygenase by binding to its central cavity: Theoretical and X-ray evidence, INT J MOL M, 6(5), 2000, pp. 521-526

Authors: McCabe, NP Angwafo, FF Zaher, A Selman, SH Kouinche, A Jankun, J

Citation: Np. Mccabe et al., Expression of soluble urokinase plasminogen activator receptor may be related to outcome in prostate cancer patients, ONCOL REP, 7(4), 2000, pp. 879-882

Authors: Swiercz, R Skrzypczak-Jankun, E Merrell, MM Selman, SH Jankun, J

Citation: R. Swiercz et al., Angiostatic activity of synthetic inhibitors of urokinase type plasminogenactivator, ONCOL REP, 6(3), 1999, pp. 523-526

Authors: Pham, C Jankun, J Skrzypczak-Jankun, E Flowers, RA Funk, MO

Citation: C. Pham et al., Structural and thermochemical characterization of lipoxygenase-catechol complexes, BIOCHEM, 37(51), 1998, pp. 17952-17957